|
Quotes & Info
|
| ICCC > SEC Filings for ICCC > Form 8-K on 30-Sep-2009 | All Recent SEC Filings |
30-Sep-2009
Other Events, Financial Statements and Exhibits
ImmuCell Announces Initial Results from its pivotal effectiveness study of Mast
Out(R).
ImmuCell's Mastitis Drug Meets Pivotal Effectiveness Study End Point.
(a) Financial statements:
None
(b) Pro forma financial information:
None
(c) Shell company transactions:
None
(d) Exhibits
99.1 Press Release of ImmuCell Corporation dated September
30, 2009
|
|